These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 17095756)

  • 1. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
    Shah YM; Morimura K; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
    Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
    Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
    Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of metallothionein in murine experimental colitis.
    Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T
    Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
    J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
    Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis.
    Yamamoto K; Ninomiya Y; Iseki M; Nakachi Y; Kanesaki-Yatsuka Y; Yamanoue Y; Itoh T; Nishii Y; Petrovsky N; Okazaki Y
    Biochem Biophys Res Commun; 2008 Mar; 367(3):566-72. PubMed ID: 18191038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
    Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
    Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
    Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
    Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
    Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
    PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.
    Hontecillas R; Horne WT; Climent M; Guri AJ; Evans C; Zhang Y; Sobral BW; Bassaganya-Riera J
    Mucosal Immunol; 2011 May; 4(3):304-13. PubMed ID: 21068720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
    Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
    J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.
    Naito Y; Takagi T; Handa O; Ishikawa T; Nakagawa S; Yamaguchi T; Yoshida N; Minami M; Kita M; Imanishi J; Yoshikawa T
    J Gastroenterol Hepatol; 2003 May; 18(5):560-9. PubMed ID: 12702049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
    Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
    Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
    Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A soybean and fish oil mixture with different n-6/n-3 PUFA ratios modulates the inflammatory reaction in mice with dextran sulfate sodium-induced acute colitis.
    Huang CH; Hou YC; Yeh CL; Yeh SL
    Clin Nutr; 2015 Oct; 34(5):1018-24. PubMed ID: 25434577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental colitis by intestinal mononuclear phagocytes.
    Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
    J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
    Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
    Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.